ECM
KYNB

Element Capital Management’s Kyntra Bio KYNB Stock Holding History

Element Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-224
Closed -$304K – 421
2019
Q1 		$304K Buy
+224
New +$304K 0.01% 584
2018
Q4 		– Sell
-222
Closed -$338K – 728
2018
Q3 		$338K Buy
+222
New +$342K 0.01% 546

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Element Capital Management's KYNB Position: Q2 2019 in Review

Element Capital Management sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 224 shares — an estimated $304K sold.

Element Capital Management first reported a position in KYNB in Q3 2018 and held it in 2 quarters. The position peaked at $338K in Q3 2018. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Element Capital Management reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Element Capital Management sold 224 Kyntra Bio shares in Q2 2019, an estimated $304K.
  • Element Capital Management first reported a position in Kyntra Bio in Q3 2018 and held it in 2 quarters.
  • Element Capital Management's Kyntra Bio position peaked at $338K in Q3 2018.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.